Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Arvinas Inc. (ARVN)

50.47   -0.23 (-0.45%) 02-21 16:00
Open: 50.58 Pre. Close: 50.7
High: 50.83 Low: 49.77
Volume: 217,434 Market Cap: 1967M
Arvinas, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company's lead products include ARV-110, proteolysis targeting chimeras (PROTAC) that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer; and ARV-471, a PROTAC targeting the estrogen receptor protein for the treatment of women with metastatic ER positive/HER2 negative breast cancer. It is also developing other PROTACs for degrading AR and other clinically relevant AR point mutations; and various other products for the treatment of neurodegenerative diseases, including tauopathies. The company has a collaboration with Bayer AG to develop novel proteolysis-targeting chimera candidates for humans and plants. Arvinas, Inc. was founded in 2015 and is based in New Haven, Connecticut.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 50.928 - 51.217 51.217 - 51.531
Low: 48.957 - 49.278 49.278 - 49.627
Close: 49.859 - 50.422 50.422 - 51.034

Technical analysis

as of: 2020-02-21 4:27:49 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 61.07     One year: 64.18
Support: Support1: 47.98    Support2: 39.92
Resistance: Resistance1: 52.29    Resistance2: 54.95
Pivot: 51.17
Moving Average: MA(5): 50.45     MA(20): 51.07
MA(100): 36.23     MA(250): 27.62
MACD: MACD(12,26): 1.09     Signal(9): 1.61
Stochastic oscillator: %K(14,3): 38.69     %D(3): 36.30
RSI: RSI(14): 52.53
52-week: High: 54.95  Low: 14.07  Change(%): 168.9
Average Vol(K): 3-Month: 35190  10-Days: 36588

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
ARVN has closed above bottom band by 38.6%. Bollinger Bands are 33.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 6) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (NASDAQ: ALEC ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Anavex Life Sciences Corp (NASDAQ: AVXL ) Arvinas Inc (NASDAQ: ARVN ) Ascendis Pharma A/S (NASDAQ: ASND ) Beam Therapeutics Inc (NASDAQ: BEAM ) (IPOed Thursday) ChemoCentryx Inc (NASDAQ: CCXI ) Eli Lilly And Co (NYSE: LLY ) Fulgent Genetics Inc (NASDAQ: FLGT ) Insmed Incorporated (NASDAQ: INSM ) Insulet Corporation (NASDAQ: PODD ) Johnson & Johnson (NYSE: JNJ ) Novartis AG (NYSE: NVS ) PPD Inc (NASDAQ: PPD ) (IPOed Thursday) Principia Biopharma Inc (NASDAQ: PRNB ) Profound Medical Corp (NASDAQ: PROF ) PTC Therapeutics, Inc (NASDAQ: PTCT ) ResMed Inc. (NYSE: RMD ) Revance Therapeutics Inc (NASDAQ: RVNC ) (announced FDA acceptance of BLA for DAXI to treat frown lines) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) Zimmer Biomet Holdings Inc (NYSE: ZBH ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on Feb.

The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom Disappointment Inflicts Pain On Durect Shares
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 16.) Acceleron Pharma Inc (NASDAQ: XLRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Arvinas Inc (NASDAQ: ARVN ) AtriCure Inc. (NASDAQ: ATRC ) AVITA MED LTD/S ADR (NASDAQ: RCEL ) ChemoCentryx Inc (NASDAQ: CCXI ) Collegium Pharmaceutical Inc (NASDAQ: COLL ) DENTSPLY SIRONA Inc (NASDAQ: XRAY ) Eli Lilly And Co (NYSE: LLY ) Epizyme Inc (NASDAQ: EPZM ) Fate Therapeutics Inc (NASDAQ: FATE ) Foamix Pharmaceuticals Ltd (NASDAQ: FOMX ) Fortress Biotech (NASDAQ: FBIO ) (announced award of pediatric disease designation for its partner company Cyprium's CUTX-101, which is being evaluated for Menkes disease) Frequency Therapeutics Inc (NASDAQ: FREQ ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Global Blood Therapeutics Inc (NASDAQ: GBT ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Hologic, Inc. (NASDAQ: HOLX ) HEALTH SCIENCES/SH (NASDAQ: IMVT ) Inspire Medical Systems Inc (NYSE: INSP ) Insulet Corporation (NASDAQ: PODD ) Johnson & Johnson (NYSE: JNJ Medtronic PLC (NYSE: MDT ) Masimo Corporation (NASDAQ: MASI ) Medpace Holdings Inc (NASDAQ: MEDP ) Mersana Therapeutics Inc (NASDAQ: MRSN ) Mesoblast limited (NASDAQ: MESO ) Minerva Neurosciences Inc (NASDAQ: NERV ) Nantkwest Inc (NASDAQ: NK ) …

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGS
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 38.98
Shares Float (M) 21.85
% Held by Insiders 16.54
% Held by Institutions 63.32
Shares Short (K) 2080
Shares Short P. Month (K)

Stock Financials

EPS -2.050
Book Value (p.s.) 4.060
PEG Ratio
Profit Margin -157.34
Operating Margin -110.01
Return on Assets (ttm) -18.5
Return on Equity (ttm) -76.6
Qtrly Rev. Growth 790.3
Gross Profit (p.s.) 0.367
Sales Per Share
EBITDA (p.s.) -1.140
Qtrly Earnings Growth
Operating Cash Flow (M) -36.70
Levered Free Cash Flow (M) -2.03

Stock Valuations

P/E -24.62
P/E Growth Ratio
P/BV 12.43
P/S 38.82
P/CF -53.61

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.